BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32040674)

  • 1. Production of a bispecific antibody targeting TNF-α and C5a in Pichia pastoris and its therapeutic potential in rheumatoid arthritis.
    Chen J; He Z; Fan Y; Zhou X; Li L; Liu M
    Biotechnol Lett; 2020 Apr; 42(4):557-569. PubMed ID: 32040674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis.
    Kang SE; Park JK; Yoo HJ; Kang HS; Park YW; Park BC; Park JE; Lee EY; Lee EB; Song YW
    Transl Res; 2021 Jun; 232():75-87. PubMed ID: 33453429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model.
    Li Q; Ren G; Xu L; Wang Q; Qi J; Wang W; Zhou B; Han X; Sun C; Wu Q; Yu Y; Peng Z; Zheng S; Li D
    Int Immunopharmacol; 2014 Jul; 21(1):119-27. PubMed ID: 24800661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.
    Wu Q; Wang Y; Wang Q; Yu D; Wang Y; Song L; Liu Z; Ye X; Xu P; Cao H; Li D; Ren G
    Immunol Lett; 2016 Nov; 179():68-79. PubMed ID: 27616043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory expression of a bispecific antibody targeting tumor necrosis factor and ED-B fibronectin in Pichia pastoris and its functional analysis.
    Liu MY; Hu XP; Xie M; Jiang SJ; Li LJ; Liu DX; Yang XS
    Biotechnol Lett; 2014 Dec; 36(12):2425-31. PubMed ID: 25129049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic efficacy of three bispecific antibodies on rheumatoid arthritis mice models].
    Li QC; Han XH; Zhou B; Wang WF; Ren GP; Sun CY; Wu Q; Yu YH; Xu LM; Wang QY; Qi JY; Wei YQ; Cao HW; Han JY; Li DS
    Yao Xue Xue Bao; 2014 Mar; 49(3):322-8. PubMed ID: 24961102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
    Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
    Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
    Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
    Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model.
    Andersson C; Wenander CS; Usher PA; Hebsgaard JB; Sondergaard BC; Rønø B; Mackay C; Friedrichsen B; Chang C; Tang R; Hornum L
    Clin Exp Immunol; 2014 Jul; 177(1):219-33. PubMed ID: 24665841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis.
    Melendez AJ; Ibrahim FB
    J Immunol; 2004 Aug; 173(3):1596-603. PubMed ID: 15265887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
    Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
    World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
    Hornum L; Hansen AJ; Tornehave D; Fjording MS; Colmenero P; Wätjen IF; Søe Nielsen NH; Bliddal H; Bartels EM
    PLoS One; 2017; 12(12):e0189017. PubMed ID: 29220376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel bispecific antibody targeting tumor necrosis factor α and ED-B fibronectin effectively inhibits the progression of established collagen-induce arthritis.
    Liu M; Xie M; Jiang S; Liu G; Li L; Liu D; Yang X
    J Biotechnol; 2014 Sep; 186():1-12. PubMed ID: 24992210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis.
    Ferrari M; Onuoha SC; Fossati-Jimack L; Nerviani A; Alves PL; Pagani S; Deantonio C; Colombo F; Santoro C; Sblattero D; Pitzalis C
    Front Immunol; 2021; 12():640070. PubMed ID: 33679801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection.
    Kacani L; Bánki Z; Zwirner J; Schennach H; Bajtay Z; Erdei A; Stoiber H; Dierich MP
    J Immunol; 2001 Mar; 166(5):3410-5. PubMed ID: 11207298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
    Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
    Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice.
    Larbouret C; Robert B; Linard C; Teulon I; Gourgou S; Bibeau F; Martineau P; Santoro L; Pouget JP; Pelegrin A; Azria D
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1231-7. PubMed ID: 17967312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.
    Vergunst CE; Gerlag DM; Dinant H; Schulz L; Vinkenoog M; Smeets TJ; Sanders ME; Reedquist KA; Tak PP
    Rheumatology (Oxford); 2007 Dec; 46(12):1773-8. PubMed ID: 17965442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and Characterization of a Bispecific Antibody Targeting Both PD-1 and c-MET.
    Wu Y; Yu M; Sun Z; Hou W; Wang Y; Yuan Q; Mo W
    Protein Pept Lett; 2018 Feb; 24(12):1105-1112. PubMed ID: 29046141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoke and C5a induce airway epithelial intercellular adhesion molecule-1 and cell adhesion.
    Floreani AA; Wyatt TA; Stoner J; Sanderson SD; Thompson EG; Allen-Gipson D; Heires AJ
    Am J Respir Cell Mol Biol; 2003 Oct; 29(4):472-82. PubMed ID: 12714373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.